Defiance Daily Target 2X Long HIMS ETF (NASDAQ:HIMZ) Stock Price Up 1.3% – Time to Buy?

Defiance Daily Target 2X Long HIMS ETF (NASDAQ:HIMZGet Free Report) shares traded up 1.3% on Monday . The stock traded as high as $36.43 and last traded at $35.35. Approximately 535,530 shares changed hands during trading, a decline of 60% from the average session volume of 1,345,978 shares. The stock had previously closed at $34.88.

Defiance Daily Target 2X Long HIMS ETF Trading Up 1.3%

The firm has a market cap of $65.40 million, a P/E ratio of 137.04 and a beta of 4.16. The stock’s fifty day moving average is $41.26 and its two-hundred day moving average is $34.42.

Institutional Investors Weigh In On Defiance Daily Target 2X Long HIMS ETF

Hedge funds have recently added to or reduced their stakes in the company. XTX Topco Ltd purchased a new stake in Defiance Daily Target 2X Long HIMS ETF during the 4th quarter valued at about $59,000. Jump Financial LLC purchased a new position in Defiance Daily Target 2X Long HIMS ETF in the 4th quarter worth approximately $75,000. Prosperitas Financial LLC bought a new stake in Defiance Daily Target 2X Long HIMS ETF in the fourth quarter valued at approximately $116,000. Finally, HRT Financial LP bought a new stake in Defiance Daily Target 2X Long HIMS ETF in the fourth quarter valued at approximately $176,000.

Defiance Daily Target 2X Long HIMS ETF Company Profile

(Get Free Report)

The Defiance Daily Target 2X Long HIMS ETF (HIMZ) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of Hims & Hers Health Inc (HIMS), less fees and expenses, through derivatives like swap agreements HIMZ was launched on Mar 12, 2025 and is issued by Defiance.

Recommended Stories

Receive News & Ratings for Defiance Daily Target 2X Long HIMS ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long HIMS ETF and related companies with MarketBeat.com's FREE daily email newsletter.